UND General Info | UND Medical School | UND Discussion | Other Sites | Look Back
Ryan Ehlis Back In School; Drug Maker
Says Extreme Reaction To Drug Rare
Ten days after he began taking a widely used medicine to control his
attention deficit disorder and help him with his college studies, Ryan
Ehlis slipped into a psychotic fog and killed his infant daughter. Ehlis declined comment on his case, but today, the 24-year-old UND student is
back home with his common-law wife and three other children, out of jail, and back in
school,
acquitted of murder by a judge who ruled his psychotic state was an
extremely rare side effect of the drug called Adderall. Ehlis said he
returned to normal days after he stopped taking the medication.
Medical experts and the drug's manufacturer say that despite the
slaying, Adderall remains a safe and effective drug for controlling
attention deficit-hyperactivity disorder (ADHD).
Within days after taking the medicine in January, Ehlis started
hearing voices. He believed God was telling him to leave his body and
bring his daughter with him to save the world, said his lawyer, John
Thelen. Psychiatrists testified before a judge that the
shootings happened solely because of a psychotic state caused by the
prescription drug. Judge Debbie Kleven agreed, ruling that Ehlis lacked
the capacity to understand what he was doing.
A spokesman for
Shire Richwood Inc., the maker of the drug stated that in very rare circumstances, it can cause psychotic episodes at recommended doses. Dr. James Swanson, a professor at the University of California at
Irvine who has studied Adderall, said he was surprised to hear of Ehlis'
violent reaction. Thelen said the drug was prescribed to Ehlis by a psychiatrist, and
Ehlis was taking the prescribed dosage. Under the judge's order, Ehlis must have independent psychiatric
evaluations, which will be reviewed at a hearing in about three months.
He really has come back, in what appears to be 100 percent of who he
was before this incident, Thelen said.
Source: Associated Press, October 30, 1999